Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Uterine Cervical Neoplasms: early-phase trial registry
2 of 9 indexed Uterine Cervical Neoplasms trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 2 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Uterine Cervical Neoplasms: 9 US clinical trials tracked, 2 recruiting.
Uterine Cervical Neoplasms is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Fenway Community Health, running 1 of these trials.
Enrollment posture brief
Registry condition uterine-cervical-neoplasms
OPEN 2 | RECR 22% | LATE 0 | EARLY 2 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acne (22% recruiting · 27 trials)
Uterine Cervical Neoplasms lists 2 open slots (22% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Uterine Cervical Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Uterine Cervical Neoplasms is recruiting below its size-band peers.
2 of 9 indexed trials (22.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Uterine Cervical Neoplasms trials is spread across many organizations.
Fenway Community Health accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Uterine Cervical Neoplasms enrolment sits around 495 participants.
Median target enrolment is 495 among the 9 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Uterine Cervical Neoplasms splits between interventional and observational designs.
6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Eli Lilly and Company
NCT06400472
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
ISA Associates
NCT07011836
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Memorial Sloan Kettering Cancer Center
NCT00579163
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Fox Chase Cancer Center
NCT04557423
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Seagen, a wholly owned subsidiary of Pfizer
NCT04579380
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
Becton, Dickinson and Company
NCT01944722
Low-Cost Molecular Cervical Cancer Screening Study
National Cancer Institute (NCI)
NCT01231945
Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients
Fenway Community Health
NCT02401867
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
University of Michigan
NCT02444195
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Uterine Cervical Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Uterine Cervical Neoplasms trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Uterine Cervical Neoplasms page
9 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Uterine Cervical Neoplasms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Fenway Community Health sponsors the most Uterine Cervical Neoplasms trials on record, review their full trial history before evaluating a specific study. See Fenway Community Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Uterine Cervical Neoplasms condition card totals 9 registered trials; most-linked intervention BD Onclarity™ HPV assay on BD Viper™ LT; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.